AFG
TMO icon

Albion Financial Group’s Thermo Fisher Scientific TMO Stock Holding History

Albion Financial Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.1M Sell
24,162
-166
-0.7% -$79.7K 0.7% 42
2026
Q1 		$12M Sell
24,328
-72
-0.3% -$39.1K 0.77% 38
2025
Q4 		$14.1M Sell
24,400
-630
-3% -$356K 0.88% 31
2025
Q3 		$12.1M Sell
25,030
-457
-2% -$213K 0.73% 40
2025
Q2 		$10.3M Sell
25,487
-83
-0.3% -$34.7K 0.68% 43
2025
Q1 		$12.7M Sell
25,570
-114
-0.4% -$61.7K 0.9% 34
2024
Q4 		$13.4M Sell
25,684
-378
-1% -$208K 0.91% 30
2024
Q3 		$16.1M Buy
26,062
+67
+0.3% +$39.7K 1.12% 28
2024
Q2 		$14.4M Sell
25,995
-182
-0.7% -$104K 1.08% 26
2024
Q1 		$15.2M Sell
26,177
-130
-0.5% -$72.9K 1.17% 24
2023
Q4 		$14M Buy
26,307
+30
+0.1% +$14.5K 1.15% 25
2023
Q3 		$13.3M Buy
26,277
+364
+1% +$194K 1.23% 24
2023
Q2 		$13.5M Sell
25,913
-1,169
-4% -$631K 1.18% 26
2023
Q1 		$15.6M Sell
27,082
-691
-2% -$389K 1.43% 19
2022
Q4 		$15.3M Buy
27,773
+87
+0.3% +$46.1K 1.48% 20
2022
Q3 		$14M Sell
27,686
-59
-0.2% -$33K 1.45% 18
2022
Q2 		$15.1M Buy
27,745
+303
+1% +$167K 1.49% 16
2022
Q1 		$16.2M Buy
27,442
+1,505
+6% +$865K 1.38% 19
2021
Q4 		$17.3M Buy
25,937
+1,643
+7% +$1.03M 1.37% 22
2021
Q3 		$13.9M Buy
24,294
+63
+0.3% +$34.6K 1.22% 26
2021
Q2 		$12.2M Buy
+24,231
New +$11.4M 1.06% 29
2020
Q4 		$9.82M Buy
21,088
+6,324
+43% +$2.97M 0.96% 30
2020
Q3 		$6.52M Buy
+14,764
New +$6.1M 0.71% 34

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Albion Financial Group's TMO Position: Q2 2026 in Review

Albion Financial Group reduced its Thermo Fisher Scientific (TMO) stake by 0.68% in Q2 2026, selling an estimated $79.7K and leaving 24,162 shares worth $12.1M. The position accounts for 0.7% of the portfolio, ranked #42.

Albion Financial Group first reported a position in TMO in Q3 2020 and has held it in 23 quarters since. The position peaked at $17.3M in Q4 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Albion Financial Group held 24,162 shares of Thermo Fisher Scientific worth $12.1M as of Q2 2026.
  • Albion Financial Group sold 166 Thermo Fisher Scientific shares in Q2 2026, an estimated $79.7K.
  • Thermo Fisher Scientific made up 0.7% of Albion Financial Group's portfolio in Q2 2026, its #42 holding.
  • Albion Financial Group first reported a position in Thermo Fisher Scientific in Q3 2020 and has held it in 23 quarters since.
  • Albion Financial Group's Thermo Fisher Scientific position peaked at $17.3M in Q4 2021.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Albion Financial Group's 13F filing for Q2 2026, filed 22 Jul 2026.